U.S., March 20 -- ClinicalTrials.gov registry received information related to the study (NCT07483398) titled 'RELIEF-PD: Crisugabalin for Nociplastic Pain in Parkinson's Disease' on March 16.
Brief Summary: The goal of this clinical trial is to evaluate the efficacy and safety of Crisugabalin in adult participants with Parkinson's disease suffering from nociceptive pain. The main question it aims to answer is:
1. Does Crisugabalin significantly reduce pain intensity compared to placebo?
2. What is the safety and tolerability profile of Crisugabalin in patients with Parkinson's disease?
Researchers will compare participants receiving Crisugabalin to those receiving a matching placebo to see if the investigational drug leads to a greater ...